Literature DB >> 11015099

All-artery multigraft coronary artery bypass grafting with only internal thoracic arteries possible and safe: a randomized trial.

W O Myers1, R Berg, J F Ray, J W Douglas-Jones, H S Maki, R H Ulmer, B R Chaitman, R A Reinhart.   

Abstract

BACKGROUND: The internal thoracic artery (ITA) bypass to the left anterior descending coronary artery is of proven benefit in multigraft coronary artery bypass. Total ITA grafts, if reoperation is averted by avoiding saphenous vein grafts (SVGs), are attractive. The safety of the total ITA graft operation (all-ITA) is a concern.
METHODS: A randomized trial of multiple-ITA bypass graftings with the use of bilateral sequential ITA without SVGs was performed. Control patients received 1 ITA plus SVG. Inclusion criteria were those used in the Coronary Artery Surgery Study, extended to age 76 years, and any angina class, except emergent. One hundred sixty-two patients were randomized (81 patients per group) from January 1, 1990, to December 31, 1994.
RESULTS: Baseline traits were similar as were cross-clamp times, pump times, and number of arteries bypassed (average, 4.3 arteries). Patients who received multiple ITA grafts had no myocardial infarctions, per reference laboratory. One patient died, and 2 patients returned for bleeding. The ITA-SVG group had similar results. The all-ITA group experienced successful completion in 93% of cases. Complications did not differ from control patients.
CONCLUSIONS: Early and 5-year outcomes were not different between the all-ITA group and the ITA with SVGs group. We believe experienced surgeons can safely extend the ITA to multibypass coronary artery bypass without use of SVG to achieve an all-ITA operation.

Entities:  

Mesh:

Year:  2000        PMID: 11015099     DOI: 10.1067/msy.2000.108113

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Unmeasured Confounders in Observational Studies Comparing Bilateral Versus Single Internal Thoracic Artery for Coronary Artery Bypass Grafting: A Meta-Analysis.

Authors:  Mario Gaudino; Antonino Di Franco; Mohamed Rahouma; Derrick Y Tam; Mario Iannaccone; Saswata Deb; Fabrizio D'Ascenzo; Ahmed A Abouarab; Leonard N Girardi; David P Taggart; Stephen E Fremes
Journal:  J Am Heart Assoc       Date:  2018-01-06       Impact factor: 5.501

2.  Evidence-based selection of the second and third arterial conduit.

Authors:  Taylor Gillmore; Rodolfo V Rocha; Stephen E Fremes
Journal:  JTCVS Open       Date:  2020-11-25

3.  Prevalence and Impact of Treatment Crossover in Cardiac Surgery Randomized Trials: A Meta-Epidemiologic Study.

Authors:  Mario Gaudino; Stephen E Fremes; Marc Ruel; Antonino Di Franco; Michele Di Mauro; Joanna Chikwe; Giacomo Frati; Leonard N Girardi; David P Taggart; Giuseppe Biondi-Zoccai
Journal:  J Am Heart Assoc       Date:  2019-10-30       Impact factor: 5.501

Review 4.  Is the Use of BIMA in CABG Sub-Optimal? A Review of the Current Clinical and Economic Evidence Including Innovative Approaches to the Management of Mediastinitis.

Authors:  Nicolai Bayer; Warren Mark Hart; Tan Arulampalam; Colette Hamilton; Michael Schmoeckel
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-09-14       Impact factor: 1.520

5.  Robustness of the Comparative Observational Evidence Supporting Class I and II Cardiac Surgery Procedures.

Authors:  Mario Gaudino; Irbaz Hameed; N Bryce Robinson; Ajita Naik; Viola Weidenmann; Yongle Ruan; Derrick Tam; Leonard N Girardi; Stephen Fremes
Journal:  J Am Heart Assoc       Date:  2020-08-20       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.